Will the U.S. Secretary of Health and Human Services propose new federal guidelines for midwifery care by December 31, 2026?

This market resolves to Yes if peer-reviewed study results published by March 2027 show that the dual-drug strategy significantly improves clinical outcomes (such as progression-free survival or overall response rate) for patients with triple-negative breast cancer compared to current standard treatments.

This market resolves to Yes if the proposed combination of healthcare providers Atrium and WakeMed receives approval from the relevant regulatory authorities by February 2027. The approval must be publicly confirmed by that date.

This market resolves to Yes if the US National Institutes of Health (NIH) publicly announces new guidelines specifically aimed at exercise for adults aged 65 and older by December 31, 2026. The announcement must be reported by a credible health or governmental news source.

This market resolves to Yes if the National Committee for Quality Assurance (NCQA) officially implements new quality measures developed in partnership with Komodo Health AI by February 28, 2027. The implementation must be publicly announced by NCQA or verifiable through reliable healthcare industry news sources.

This market resolves to Yes if Medicaid enrollment in Illinois, as reported by the Illinois Department of Healthcare and Family Services, decreases by more than 10% from its current figures by December 31, 2027.

This market resolves to Yes if a wearable smart patch designed to automatically deliver aid during a fentanyl overdose receives FDA approval by December 31, 2026. If the FDA does not approve such a device by this date, it resolves to No.